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The Distinct Roles of TRAF2 and RIP in IKK
Activation by TNF-R1: TRAF2 Recruits IKK
to TNF-R1 while RIP Mediates IKK Activation
The molecular mechanisms that regulate TNF-medi-
ated responses have been intensively studied in recent
years. For TNF-R1 signaling, it is known that the binding
of TNF to TNF-R1 leads to the recruitment of TRADD
(TNF-R1-associated death domain protein) into the re-
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recruits other effector proteins into the complex. FADD/National Cancer Institute
MORT1 (FAS-associated death domain protein), TRAF2National Institutes of Health
(TNFR-associated factor 2), and the death domain ki-Bethesda, Maryland 20892
nase RIP (receptor interacting protein) not only are re-²University of Massachusetts Medical Center
cruited but also have been shown to interact directlyWorcester, Massachusetts 01605
with TRADD (Rothe et al., 1994, 1995; Boldin et al., 1995;
Chinnaiyan et al., 1995; Hsu et al., 1995, 1996a, 1996b;
Stanger et al., 1995). While FADD/MORT1 is essentialSummary
for TNF-induced apoptosis, RIP and TRAF2 seem to be
involved in both NF-kB and JNK activation (Liu et al.,The death domain kinase RIP and the TNF receptor-
1996; Ting et al., 1996; Lee, S.Y. et al., 1997; Natoli etassociated factor 2 (TRAF2) are essential effectors in
al., 1997; Reinhard et al., 1997; Yeh et al., 1997; KelliherTNF signaling. To understand the mechanism by which
et al., 1998; Zhang et al., 1998). There is also cross-RIP and TRAF2 regulate TNF-induced activation of the
regulation between these distinct pathways. For in-transcription factor NF-kB, we investigated their re-
stance, RIP is cleaved by Caspase-8 during apoptosisspective roles in TNF-R1-mediated IKK activation us-
and this cleavage plays a role in regulating the balanceing both RIP2/2 and TRAF22/2 fibroblasts. We found
between life and death in response to TNF (Lin et al.,that TNF-R1-mediated IKK activation requires both
1999). On the other hand, the occupancy of TNF-R2 byRIP and TRAF2 proteins. Although TRAF2 or RIP can
TNF leads to the recruitment of TRAF1 and TRAF2 asbe independently recruited to the TNF-R1 complex,
well as cIAP1 and cIAP2 (Rothe et al., 1994, 1995). How-neither one of them alone is capable of transducing
ever, it is less clear how these molecules correlate tothe TNF signal that leads to IKK activation. Moreover,
transduce the diverse TNF signals through TNF-R2. Re-we demonstrated that IKK is recruited to the TNF-R1
cently, the indispensable role of RIP in TNF-induced NF-complex through TRAF2 upon TNF treatment and that
kB activation was suggested by generating RIP-defi-IKK activation requires the presence of RIP in the same
cient Jurkat cells and RIP2/2 mice (Ting et al., 1996;complex.
Kelliher et al., 1998). In contrast, the study with TRAF22/2
cells indicated that TRAF2 is essential for TNF-inducedIntroduction
JNK activation, and TNF-induced NF-kB activation is
just delayed and slightly reduced in those cells (Yeh etThe proinflammatory cytokine tumor necrosis factor
al., 1997).(TNF) plays an important role in diverse cellular events
Downstream to these effector molecules, the activa-such as septic shock, induction of other cytokines, cell
tion of NF-kB and JNK in response to TNF is regulatedproliferation, differentiation, and apoptosis (Tartaglia
by distinct pathways. While NF-kB is activated throughand Goeddel, 1992; Rothe et al., 1992; Tracey and Cer-
IKK and MAP3K, NIK, or MEKK1 (Chen et al., 1996; Lee,
ami, 1993). Many of these TNF-induced processes can
S.Y. et al., 1997; Malinin et al., 1997), JNK activity is
be mediated by either one of the two TNF receptors,
regulated by JNKK1/MKK4 and MEKK1 (DeÂ rijard et al.,
TNF-R1 and TNF-R2, both of which belong to the TNF 1995; Karin, 1995; Lin et al., 1995; Liu et al., 1996; Natoli
receptor superfamily (Smith et al., 1994; Nagata and et al., 1997). Inactive NF-kB is sequestered in the cyto-
Golstein, 1995). In response to TNF treatment, the tran- plasm through its interaction with the inhibitory proteins,
scription factor NF-kB and c-Jun N-terminal kinase known as IkBs (Siebenlist et al., 1994; Baeuerle and
(JNK) are activated in most types of cells and, in some Baltimore, 1996). In response to various stimuli, IkBs
cases, apoptosis can also be induced (Brenner et al., are phosphorylated by IKK at serines 32 and 36 and are
1989; DeÂ rijard et al., 1994). However, induction of apo- rapidly degraded by the proteasome after polyubiquitin-
ptosis is achieved mainly through TNF-R1, which is also ation. The degradation of IkBs results in the release of
known as a death receptor (Vandenabeele et al., 1995; NF-kB and allows its translocation into the nucleus and
Nagata, 1997; Ashkenazi and Dixit, 1998). Activation of the subsequent activation of its target genes (Baeuerle
the NF-kB and JNK pathways plays an important role in and Baltimore, 1996). IKK is composed of three subunits:
the induction of many cytokines and immunoregulatory IKKa, IKKb, and IKKg/NEMO (DiDonato et al., 1997;
proteins and is pivotal for many inflammatory responses Mercurio et al., 1997; Regnier et al., 1997; Woronicz et
(Siebenlist et al., 1994; Baeuerle and Baltimore, 1996; al., 1997; Zandi et al., 1997; Rothwarf et al., 1998; Ya-
Karin et al., 1997). maoka et al., 1998; Hu et al., 1999; Li et al., 1999). Both
IKKa and IKKb are catalytic subunits while IKKg is a
regulatory subunit.³ To whom correspondence should be addressed (e-mail: zgliu@
helix.nih.gov). In order to understand the mechanism of TNF-induced
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Figure 1. TNF-R1-Mediated IKK Activation Requires both TRAF2 and RIP
(A) Mouse TNF-induced IKK activation in wild-type, RIP2/2, and TRAF22/2 fibroblasts. Mouse fibroblasts were treated with mouse TNF (40
ng/ml) for various times as indicated on the figure or left untreated as a control. Cell extracts were either immunoprecipitated with anti-IKKa
antibody to perform a kinase assay or resolved on SDS-PAGE for Western blotting with anti-IkB or anti-IKKa.
(B) Protein expression levels of RIP, TRAF2, TRADD, TNF-R1, and TNF-R2 in wild-type, RIP2/2, and TRAF22/2 cells. The same amount of cell
extract from each cell line was applied to SDS-PAGE for Western blottings with anti-TRAF2, anti-RIP, anti-TRADD, anti-TNF-R1, and anti-
TNF-R2 antibodies.
(C) Human TNF-induced IKK activation in wild-type, RIP2/2, and TRAF22/2 fibroblasts. Wt, RIP2/2, and TRAF22/2 fibroblasts were treated with
mouse TNF (40 ng/ml) or with human TNF (40 ng/ml) for 5 min. Nontreated cells were used as controls. Cell extracts were quantified by protein
assay and were then either immunoprecipitated with anti-IKKa antibody to perform a kinase assay or resolved on SDS-PAGE for Western
blotting with anti-IKKa antibody.
(D) IL-1-induced IKK activation. Wt, RIP2/2, and TRAF22/2 fibroblasts were either left untreated or treated with IL-1 (4 ng/ml) for 5 min for IKK
kinase assay. Cell extracts were normalized according to protein assay and then either immunoprecipitated with anti-IKKa antibody to perform
a kinase assay or resolved on SDS-PAGE for Western blotting with anti-IKKa antibody.
IKK activation, we investigated the role of RIP and both RIP and TRAF2 are required for IKK activation
through TNF-R1. Although RIP or TRAF2 can be re-TRAF2 in TNF-R1-mediated IKK activation in wild-type,
RIP2/2, and TRAF22/2 fibroblast cells. We found that cruited to the TNF-R1 complex independently of one
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another, the recruitment of either one of them alone is
not sufficient to activate IKK. Importantly, we demon-
strated that IKK is recruited to the TNF-R1 complex in
response to TNF treatment and that TRAF2 plays an
essential role in IKK recruitment. Furthermore, RIP,
which is not necessary for IKK recruitment, mediates
IKK activation.
Results
Both RIP and TRAF2 Are Required
for TNF-R1-Mediated IKK Activation
Previous studies have shown that TNF-induced NF-kB
activation is abolished in RIP-deficient Jurkat cells and
RIP2/2 cells (Ting et al., 1996; Kelliher et al., 1998) and
is just delayed and slightly reduced in TRAF22/2 cells
(Yeh et al., 1997). Because IKK activation is essential
for TNF-induced NF-kB activation, we measured IKK
activation following TNF treatment in wild-type (wt),
RIP2/2, and TRAF22/2 fibroblast cell lines by performing
an in vitro kinase assay with GST-IkB (1-54) as a sub-
strate (DiDonato et al., 1997). In these experiments,
mouse TNFa (mTNFa) was used to treat the cells be-
cause it binds to both TNF-R1 and TNF-R2 (Lewis et al.,
1991). As shown in Figure 1A, top panel, IKK is quickly
activated in wt fibroblast cells in response to TNF treat-
ment and its activation is decreased after 15 min of
treatment. In contrast, IKK activation is almost com-
pletely abolished in RIP2/2 cells and dramatically re-
duced in TRAF22/2 cells, although the IKK expression
levels in these two cell lines are similar to that of wt
cells (Figure 1A). As IKK is responsible for IkB phosphor-
ylation, which is a crucial step for TNF-induced IkB deg-
radation, we tested IkB degradation following TNF treat-
ment in these cells by Western blotting. Consistent with
the levels of IKK activation in those cell lines, TNF-
induced IkB degradation is also altered: while IkB is
rapidly degraded in wt cells after TNF treatment, no or
only partial IkB degradation was detected in RIP2/2 and
TRAF22/2 cells, respectively (Figure 1A, bottom panel).
Since IkB expression is regulated by NF-kB (Baeuerle
Figure 2. Reconstitution of TNF-Induced IKK Activation in RIP2/2
and Baltimore, 1996) and the reduced IkB level followingand TRAF22/2 Fibroblasts
TNF engagement returned to the one of nontreated cells(A) Reconstitution of TNF-induced IKK activation in RIP2/2 fibro-
by 60 min after treatment (Figure 1A, bottom panel),blasts. Wt or RIP2/2 cells were transfected with 2 mg of either the
the partial IkB degradation seemed to be sufficient toMyc-RIP expression plasmid or an empty vector in 100 mm dishes.
Twenty-four hours after transfection, half of the transfected cells activate NF-kB in TRAF22/2 cells. IKK protein levels were
were treated with 40 ng human TNF for 5 min. Cell extracts were also determined by Western blotting in these experi-
quantified by protein assay and were then either immunoprecipi- ments as a control. The protein expression levels of RIP,
tated with anti-IKKa antibody to perform a kinase assay or resolved
TRAF2, TRADD, TNF-R1, and TNF-R2 in wt, RIP2/2, andon SDS-PAGE for Western blotting with anti-IKKa or anti-Myc an-
TRAF22/2 cells were measured by Western blotting. Astibody.
shown in Figure 1B, the expression level of each protein,(B) Reconstitution of TNF-induced IKK activation in TRAF22/2 fibro-
blasts. Wt or TRAF22/2 cells were transfected with 2 mg of either when present, is similar in each of the three cell lines.
the Flag-TRAF2 expression plasmid or an empty vector in 100 mm Mouse TNF binds to both TNF-R1 and TNF-R2, and
dishes. Twenty-four hours after transfection, half of the transfected these two receptors elicit certain overlapping responses.
cells were treated with 40 ng human TNF for 5 min. Cell extracts
In order to investigate the requirement of RIP and TRAF2were quantified by protein assay and were then either immunopre-
in TNF-R1-mediated IKK activation, IKK activation wascipitated with anti-IKKa antibody to perform a kinase assay or re-
solved on SDS-PAGE for Western blotting with anti-IKKa or anti-
Flag.
(C) Reconstitution of TNF-induced IKK activation in RIP2/2 and
TRAF22/2 fibroblasts by transient cotransfection. Wt, RIP2/2, or cells were treated with 40 ng mouse TNF for 5 min. HA-IKKb content
TRAF22/2 cells were transfected with 1 mg of the HA-IKKb expres- was quantified by Western blotting with anti-HA antibody, and cell
sion plasmid and 0.5 mg of either the Flag-TRAF2 expression plas- extracts were then immunoprecipitated with anti-HA antibody to
mid, the Myc-RIP expression plasmid or an empty vector in 60 mm perform a kinase assay or resolved on SDS-PAGE for Western blot-
dishes. Twenty-four hours after transfection, half of the transfected ting with anti-RIP or anti-TRAF2 antibody.
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determined in these fibroblast cell lines following human bind to each other (Hsu et al., 1996b), it is not clear
whether the interaction between RIP and TRAF2 is re-TNFa (hTNFa) treatment, which only binds to TNF-R1
quired for their recruitment to the TNF-R1 complex. To(Lewis et al., 1991). As shown in Figure 1C, IKK activation
address this question, we tested whether RIP andis slightly decreased in wt cells treated with hTNFa when
TRAF2 can be recruited to the TNF-R1 complex inde-compared to mTNFa treatment, indicating a minor con-
pendently of one another. In these experiments, TNF-tribution of TNF-R2 in IKK activation. A similar observa-
R1 from either untreated or TNF-treated wt, RIP2/2, andtion was also made with TRAF22/2 cells although the
TRAF22/2 fibroblasts was immunoprecipitated, andmTNF-induced IKK activation is already impaired. As
Western blotting was performed sequentially with anti-shown in Figure 1C, IKK activation is barely detected in
RIP, anti-TRAF2, and anti-TRADD antibodies. Consis-TRAF22/2 cells after hTNF treatment. In RIP2/2 cells, no
tent with previous reports (Shu et al., 1996; Lin et al.,difference in the marginal IKK activation was detected
1999), TNF treatment induces TRADD, RIP, and TRAF2after either mTNF or hTNF treatment (Figure 1C). More-
recruitment to the TNF-R1 complex in wt cells (Figureover, IKK activation in response to IL-1 treatment is
3A). Nontreated fibroblasts were used as a negativenormal in both RIP2/2 and TRAF22/2 cells compared to
control, indicating none of these proteins were pulledwt cells, as shown in Figure 1D, which indicates that
down nonspecifically by the anti-TNF-R1 antibody. Asthis protein is activated normally in response to other
shown in Figure 3A, TNF-induced recruitment of RIPstimuli in those cells. Taken together, these results sug-
and TRAF2 were also detected in TRAF22/2 and RIP2/2gested that both RIP and TRAF2 are essential for TNF-
cells, respectively. These results suggested that RIPinduced IKK activation via TNF-R1.
and TRAF2 are recruited independently of one another.To rule out the possibility that some defects in the
Because IKK could not be activated through TNF-R1 inTNF-R1-mediated IKK activation pathway are present
the absence of RIP or TRAF2 (Figure 1), these resultsin RIP2/2 or TRAF22/2 cells, we tested whether TNF-R1-
demonstrated that RIP or TRAF2 recruitment to TNF-mediated IKK activation could be reconstituted in these
R1 is not sufficient to activate IKK. Unexpectedly, acells. To do so, we ectopically expressed Myc-RIP and
significant increased amount of TRADD and TRAF2 wasFlag-TRAF2 in RIP2/2 and TRAF22/2 cells, respectively,
recruited to TNF-R1 upon TNF treatment in RIP2/2 cellsand treated the transfected cells with hTNF. Transfected
(Figure 3A). Since the expression levels of these twowt cells were used as a control. As shown in Figure 2A,
proteins and TNF-R1 in RIP2/2 cells are similar to thosetop panel, RIP expression is able to restore the IKK
in wt cells (Figures 1B and 3A), this observation indicatedactivation in response to hTNF treatment in RIP2/2 cells.
that RIP might compete with TRADD for binding to TNF-The expression levels of IKK and Myc-RIP were also
R1 in response to TNF treatment in wt cells. In TRAF22/2measured by Western blotting (Figure 2A, middle and
cells, both RIP and TRADD are recruited to TNF-R1 uponbottom panels). In these experiments, the endogenous
TNF treatment in a fashion comparable to the one seenIKK was immunoprecipitated for in vitro kinase assays.
in wt cells.Because only a certain percentage of cells was trans-
However, the accuracy of these results relies uponfected with Myc-RIP, hTNF-induced IKK activation was
the amount of TNF-R1 pulled down from each sample.partially reconstituted in those RIP2/2 cells. Thus, lower
Because the size of the TNF-R1 is about the same asIKK activation was detected in reconstituted RIP2/2 cells
the size of the antibody heavy chain, it is impossible tocompared to wt cells, which contain an endogenous
examine the precipitation of TNF-R1 by probing theRIP protein, although similar amounts of IKK were used
same blot with anti-TNF-R1 antibody. To check the pre-in each kinase assay (Figure 2A, top and middle panels).
cipitation of TNF-R1, we crossed-linked the anti-TNF-Similarly, the ectopic-expression of Flag-TRAF2 also re-
R1 antibody to protein A-Sepharose beads with dimethylstored hTNF-induced IKK activation in TRAF22/2 cells
pimelimidate (DMP) and then performed immunoprecip-(Figure 2B, top panel). The IKK and Flag-TRAF2 expres-
itation experiments again. As shown in Figure 3B, top
sion levels in these experiments were shown in Figure
panel, DMP efficiently linked the antibody to protein A
2B, middle and bottom panels. To further confirm the
beads, and no antibody was released from beads after
results of these reconstitution experiments, either Myc- boiling. Similar amount of TNF-R1, about 10% of input,
RIP or Flag-TRAF2 was cotransfected with HA-IKKb into was precipitated from each sample (Figure 3B, middle
RIP2/2 or TRAF22/2 cells, respectively. Then, the trans- panel). The same blot was also probed with anti-TRADD
fected HA-IKKb was immunoprecipitated for in vitro ki- antibody, and as shown in Figure 3B, bottom panel, the
nase assay in order to examine the reconstitution of results of TRADD coprecipitation was similar to those
TNF-induced IKK activation. As shown in Figure 2C, in Figure 3A.
these experiments with transfected IKKb verified the To be sure that the increased recruitment of TRADD
results obtained from measuring the endogenous IKK and TRAF2 upon TNF treatment in RIP2/2 cells is indeed
activity. Taken together, these reconstitution experi- due to RIP deletion and is not a peculiar feature of the
ments further supported that the failure of IKK activation RIP2/2 fibroblasts, we performed the same experiment
in response to TNF treatment in RIP2/2 or TRAF22/2 cells in wt and RIP-deficient Jurkat cells. As shown in Figure
is due to the absence of RIP or TRAF2. 3C, results similar to those described above were ob-
tained in these Jurkat cells: an increased amount of
IKK Is Recruited to the TNF-R1 Complex TRADD and TRAF2 are present in the TNF-R1 complex in
through TRAF2 RIP-deficient Jurkat cells after TNF engagement. These
In order to transduce TNF signals, both RIP and TRAF2 results indicated that the presence of RIP minimized the
need to be recruited to the TNF-R1 complex by TRADD recruitment of TRADD to the TNF-R1 complex.
In response to TNF, it is thought that the recruitment(Hsu et al., 1996a, 1996b). Because RIP and TRAF2 can
Distinct Roles of TRAF2 and RIP in IKK Activation
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of TRAF2 and RIP would result in the activation of an
IKK kinase such as NIK or MEKK1, which in turn would
activate IKK (Malinin et al., 1997; Mercurio et al., 1997;
Regnier et al., 1997). However, since IKK activation can
be detected within a minute after TNF treatment (DiDo-
nato et al., 1997), it is possible that such a quick re-
sponse is achieved by the recruitment of IKK to the TNF-
R1 complex. To test this hypothesis, using anti-IKKa
and anti-IKKb antibodies, we performed Western blot-
ting with the same blots generated in the experiments
shown in Figure 3. We found that IKKa and IKKb were
coimmunoprecipitated with TNF-R1 upon TNF treat-
ment in wt cells (Figure 4A, lanes 1 and 2). IKKa and
IKKb were not detected in the TNF-R1 complex in
TRAF22/2 cells (Figure 4A, lanes 5 and 6). Surprisingly,
in RIP2/2 cells, IKKa and IKKb were also recruited to
the TNF-R1 complex after TNF treatment (Figure 4A,
lanes 3 and 4). The IKK expression levels in these three
cell lines are similar (Figure 4A, lanes 7, 8, and 9). These
results suggested that IKK is recruited to the TNF-R1
complex in response to TNF treatment, and its recruit-
ment requires TRAF2. Identical results were obtained
when probing the blot of Figure 3C: IKKa and IKKb were
detected in TNF-R1 complexes immunoprecipitated
from wt and RIP-deficient Jurkat cells (Figure 4B and
data not shown).
To further confirm this observation, we performed
Western blotting with the anti-IKKa and anti-IKKb anti-
bodies after immunoprecipitation experiments with an
anti-TRAF2 antibody in wt and RIP-deficient Jurkat cells.
As shown in Figure 4C, left side, top and middle panels,
both IKKa and IKKb were coimmunoprecipitated by the
anti-TRAF2 antibody after TNF treatment in both wt and
RIP-deficient Jurkat cells. Small amounts of IKKa and
IKKb were also detected in the immunoprecipitants from
nontreated wt and RIP-deficient Jurkat cells (Figure 4C,
left side, top and middle panels). This interaction is not
due to a cross-reaction of the anti-TRAF2 antibody with
IKK, since no IKK was detected in the immunoprecipi-
tant generated with the same anti-TRAF2 antibody from
TRAF22/2 cells (data not shown). RIP was also coimmu-
noprecipitated with TRAF2 in TNF-treated Jurkat cells
but not in nontreated wt Jurkat cells (Figure 4C, left side,
bottom panel). As stressed for the TNF-R1 immunopre-Figure 3. The Recruitment of RIP and TRAF2 to TNF-R1
cipitation, the accuracy of these results relies upon the(A) Recruitment of RIP and TRAF2 to TNF-R1 is independent of one
another. Cell extracts were prepared from wt, RIP2/2, and TRAF22/2 amount of TRAF2 pulled down in the different condi-
fibroblasts either treated with 40 ng/ml mTNF or untreated. After tions. Because the size of TRAF2 is close to the size of
normalization of protein content according to the protein assay, the antibody heavy chain, it is difficult to detect TRAF2
cell extracts were immunoprecipitated with anti-TNF-R1 antibody
overnight. Immunoprecipitants were resolved by SDS-PAGE, and
Western blotting was performed with anti-RIP (top), anti-TRAF2
(middle), or anti-TRADD (bottom), respectively. One percent of cell precipitated overnight with anti-TNF-R1 antibody coupled with pro-
extract from each treated sample was used as a control for protein tein A beads. Immunoprecipitants were resolved by SDS-PAGE,
content (input). and Western blotting was performed with anti-TNF-R1 (top) or anti-
(B) Similar amounts of TNF-R1 was immunoprecipitated from each TRADD antibody (bottom). One percent of cell extract from each
sample. The TNF-R1 antibody was coupled to the protein A-Sepha- treated sample was used as a control for protein content (input).
rose beads with dimethyl pimelimidate (DMP) as described in the (C) TRADD and TRAF2 are recruited to TNF-R1 more efficiently in
Experimental Procedures section. Coupling efficiency was exam- the absence of RIP. Cell extracts were prepared from wt and RIP-
ined by Coomassie blue staining. Top panel, all three samples were deficient Jurkat cells either treated with 100 ng/ml hTNF or un-
boiled for 3 min before loading: lane 1, 0.5 mg of TNF-R1 antibody treated. After normalization of the protein content according to the
was loaded as a control; lane 2, TNF-R1 antibody mixed with the protein assay, cell extracts were immunoprecipitated with the anti-
beads before coupling; lane 3, TNF-R1 antibody mixed with the TNF-R1 antibody overnight. Immunoprecipitants were resolved by
beads after coupling. Middle and bottom panels, cell extracts were SDS-PAGE, and Western blotting was performed with anti-RIP (top),
prepared from wt, RIP2/2, and TRAF22/2 fibroblasts either treated anti-TRAF2 (middle), or anti-TRADD (bottom), respectively. As a
with 40 ng/ml mTNF or untreated. After normalization of protein control for protein content, one percent of cell extract from each
content according to the protein assay, cell extracts were immuno- sample was loaded on the gel (input).
Immunity
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Figure 4. IKK Is Recruited to TNF-R1 by TRAF2 upon TNF Treatment
(A) IKK recruitment in wt, RIP2/2, and TRAF22/2 cells. The Western blot from Figure 3A was probed with anti-IKKa and anti-IKKb antibodies
sequentially.
(B) IKK recruitment in wt and RIP-deficient Jurkat cells. The Western blot from Figure 3C was probed with anti-IKKa antibody.
(C) IKK is coimmunoprecipitated with TRAF2. Cell extracts were prepared from wt and RIP-deficient Jurkat cells either treated (100 ng/ml
human TNF) or untreated. After normalization of the protein content according to the protein assay, cell extracts were immunoprecipitated
with anti-TRAF2 antibody overnight. Left panel shows immunoprecipitates as well as 1% of the cell extracts were resolved by SDS-PAGE,
and Western blotting was performed with anti-IKKa (top), anti-IKKb (middle), and anti-RIP (bottom) antibodies sequentially. Right panel, in
order to determine the relative amount of TRAF2 pulled down, TRAF2 antibody was coupled to the protein A beads as described in the
Experimental Procedures section, and the immunoprecipitation was performed as described for the left panel. Again, immunoprecipitates as
well as 1% of the cell extracts were resolved by SDS-PAGE, and Western blotting was performed with anti-TRAF2.
(D) IKKg/NEMO is recruited to the TNF-R1 complex. Cell extracts were prepared from wt fibroblasts either treated with 40 ng/ml mTNF or
untreated. After normalization of protein content according to the protein assay, cell extracts were immunoprecipitated overnight with anti-
TNF-R1 antibody coupled with protein A beads. Immunoprecipitants were resolved by SDS-PAGE, and Western blotting was performed with
anti-IKKg (top) or anti-TRADD (bottom). One percent of untreated cell extract was used as a control for protein content (input).
(E) IKK is activated in the TNF-R1 complex. Wt fibroblasts were treated with mTNF (40 ng/ml) or IL-1 (4 ng/ml) for various times as indicated
in the figure or left untreated as a control (lanes 1 and 6). After normalization of the protein content according to the protein assay, cell extracts
were immunoprecipitated with either anti-IKKa antibody or anti-TNF-R1 antibody to perform a kinase assay.
with the same antibody when it was also used in immu- might be some weak interaction between TRAF2 and
IKK before TNF treatment, and this interaction isnoprecipitation. To check the precipitation of TRAF2,
we cross-linked the anti-TRAF2 antibody to protein strengthened by TNF treatment. Importantly, because
it is observed in RIP deficient cells, this interaction isA-Sepharose beads with DMP and then performed im-
munoprecipitation experiments. As shown in Figure 4C, independent of RIP.
Since IKKg/NEMO is essential for IKK activation (Ya-right panel, similar amount of TRAF2 was precipitated
from each sample. These results indicated that there maoka et al., 1998), it is important to know whether it
Distinct Roles of TRAF2 and RIP in IKK Activation
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Figure 5. The Dominant-Negative Mutant TRAF2, TRAF2(87-501), Is
Defective in IKK Recruitment
Cell extracts were prepared from wt and the TRAF2D-TRAF22/2 (the
Flag-TRAF2(87-501) stable cell line) cells either treated with 40 ng/
ml mTNF or untreated. After normalization of protein content ac-
cording to the protein assay, cell extracts were immunoprecipitated
overnight with the anti-TNF-R1 antibody coupled to protein A beads.
Immunoprecipitants were resolved by SDS-PAGE, and Western
blotting was performed with anti-TRAF2 and anti-Flag sequentially
(top), anti-IKKa (second panel), anti-TRADD (third panel), or anti-
TNF-R1 antibody (bottom). One percent of cell extract from each Figure 6. TNF-Induced IKK Activation Does Not Requir the Kinase
sample was used as a control for protein content (input). Activity of RIP
(A) The kinase activity of RIP is not essential for TNF-induced IKK
activation. RIP2/2 cells were transfected with 2 mg of an emptyis also recruited to the TNF-R1 complex. Because the
vector, the expression plasmid for Xpress-RIP (K45A), or the expres-size of IKKg is close to the size of the antibody heavy
sion vector for Xpress-RIP in 100 mm dishes. Twenty-four hours
chain, we cross-linked TNF-R1 antibody to protein after transfection, half of transfected cells were treated with 40 ng
A-Sepharose beads and then performed immunoprecip- hTNF for 5 min. Cell extracts were quantified by protein assay and
itation experiments with extracts from TNF-treated and were then either immunoprecipitated with anti-IKKa antibody to
perform a kinase assay or resolved on SDS-PAGE for Western blot-untreated wt fibroblast cells. As shown in Figure 4D,
ting with anti-IKKa or anti-Xpress antibodies.IKKg was also recruited to the TNF-R1 complex upon
(B) MEKK1 is not detected in the TNF-R1 complex. Cell extractsTNF treatment. The same blot was also probed with
were prepared from wt fibroblasts either treated with 40 ng/ml mTNF
anti-TRADD, as shown in the bottom panel of Figure 4D. for 2, 5, and 10 min or untreated. After normalization of protein
Next, we investigated whether IKK is activated after content according to the protein assay, cell extracts were immuno-
its recruitment to the TNF-R1 complex. To do so, we precipitated with anti-TNF-R1 antibody overnight. Immunoprecipi-
tants were resolved by SDS-PAGE, and Western blotting was per-performed in vitro kinase assays with the immunoprecip-
formed with anti-MEKK1 (top), anti-RIP (second panel), anti-IKKaitants generated with the anti-TNF-R1 antibody from
(third panel), or anti-TRAF2 antibody (bottom). As a control for pro-wt fibroblasts. In these experiments, cells were treated
tein content, one percent of cell extract from each sample was also
with TNF for 2, 3.5, and 5 min or IL-1 for 5 min. One loaded on the gel (input).
percent of the total cell extract of each sample, which
was used for TNF-R1 immunoprecipitation, was used
for the regular kinase assay as described in Figure 1. stably introduced Flag-TRAF2(87-501) into TRAF22/2
cells and performed immunoprecipitation experimentsAs shown in Figure 4E, the treatment of TNF or IL-1
induced IKK activation (lanes 2±5). But with the immuno- with this stable cell line and the wt fibroblasts. In these
experiments, the anti-TNF-R1 antibody was cross-linkedprecipitants, IKK activation was only detected in those
samples from TNF-treated cells (Figure 4D, lanes 6, 7, to protein A-Sepharose beads. As shown in Figure 5,
top two panels, both wt and Flag-TRAF(87-501) wereand 8). The IKK activity in the immunoprecipitants from
cells treated with TNF for 3.5 and 5 min was significantly recruited to the TNF-R1 upon TNF treatment, but the
Flag-TRAF2(87-501) failed to recruit any IKKa. TRADDhigher than that from cells treated for 2 min. No IKK
activity was observed in the immunoprecipitants from was recruited to the TNF-R1 complex normally in this
Flag-TRAF2(87-501) stable cell line (Figure 5, the secondnontreated or IL-1-treated cells (Figure 4D, lanes 6 and
10). Because the amount of IKK recruited to the TNF- bottom panel). Similar amounts of TNF-R1 were precipi-
tated from each sample (Figure 5, bottom panel). TheseR1 complex after 2, 3.5, or 5 min TNF treatment is similar
(data not shown but see Figure 6B), these results dem- results suggested that the ring finger domain of TRAF2
was critical for recruiting IKK.onstrated that the recruited IKK was activated in the
TNF-R1 complex.
It is known that the TRAF2 mutant TRAF2(87-501), RIP but Not Its Kinase Activity Is Required
for IKK Activationwhose ring finger domain is deleted, functions as a dom-
inant-negative mutant on TNF-induced NF-kB activation It has been suggested that the kinase activity of RIP is
not essential for RIP to mediate TNF-induced NF-kBwhen it is overexpressed (Rothe et al., 1995). Therefore,
it is important to know whether TRAF2(87-501) is defec- activation (Hsu et al., 1996b; Ting et al., 1996). To be sure
that this is also true for IKK activation, we investigatedtive in IKK recruitment. To address this question, we
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whether the kinase dead RIP(K45A) is able to restore
TNF-induced IKK activation in RIP2/2 fibroblasts. We
ectopically expressed wt RIP or RIP(K45A) in RIP2/2
cells and treated half of the transfected cells with hTNF.
Cells transfected with an empty vector were used as a
control. As shown in Figure 5A, top panel, the kinase-
deficient RIP(K45A) restored the TNF-induced IKK acti-
vation as efficiently as the wt RIP did. The expression
levels of IKK, RIP(K45A), and RIP were measured by
Western blotting (Figure 6A, middle and bottom panels).
These results suggested that the kinase activity of RIP
is not required for TNF-induced IKK activation. Since
IKK is activated in the TNF-R1 complex (Figure 4D), the
role of RIP in IKK activation is most likely the recruitment
of an IKK kinase to the TNF-R1 complex.
Several kinases including NIK, MEKK1, and AKT have
been suggested to play an important role in TNF-induced
NF-kB activation (Lee, F.S. et al., 1997; Lee, S.Y. et al.,
1997; Malinin et al., 1997; Nemoto et al., 1998; Ozes et
Figure 7. The Distinct Roles of TRAF2 and RIP in TNF-R1-Mediatedal., 1999). To examine whether any of these kinases are
IKK Activationpresent in the same TNF-R1 complex as IKK is, we
In response to TNF treatment, IKK is recruited to the TNF-R1 com-performed a time course study with a TNF-R1 immuno-
plex, and this recruitment is accomplished through TRAF2. Theprecipitation experiment. Wt fibroblast cells were
activation of IKK in the TNF-R1 complex requires the presence of
treated with TNF for 0, 2, 5, and 10 min before they were RIP.
collected. As seen in Figure 6B, while RIP, IKKa, and
TRAF2 were existent in the immunoprecipitants from all
of the TNF-treated cells, no MEKK1 was detected. We effect on IKK recruitment, its presence in the same re-
also failed to observe the presence of NIK and AKT in ceptor complex is crucial for TNF-induced IKK activa-
the TNF-R1 complex when we probed the same blot tion. Because IKK is activated in the TNF-R1 complex
with anti-NIK and anti-AKT antibodies (data not shown). and the kinase activity of RIP is dispensable for IKK
Therefore, according to these results, it is not clear activation (Figures 5 and 6), the most likely function of
whether any of those kinases is the IKK kinase that RIP is to recruit the IKK kinase to the TNF-R1 complex.
activates IKK in response to TNF treatment. Previous studies have suggested that TRAF2 is solely
responsible for TNF-induced JNK activity; however,
TNF-induced NF-kB activation is slightly delayed and
Discussion decreased in TRAF2 null cells (Yeh et al., 1997). In our
study, we found that mTNF-induced IKK activation is
Tremendous efforts have been made to study the molec- significantly reduced in TRAF22/2 cells compared to wt
ular mechanisms of TNF-mediated cellular responses cells, but the remaining IKK activity is sufficient for NF-
in recent years. It is known that the activation of the kB activation (Figure 1A). Our data suggested that the
transcription factor NF-kB plays a critical role in many decrease of IKK activation is accountable for the de-
TNF-induced biological processes (Siebenlist et al., layed and slightly reduced NF-kB activation in TRAF22/2
1994; Baeuerle and Baltimore, 1996; Karin et al., 1997). cells. Importantly, unlike mTNF, hTNF induced little IKK
The signal transduction pathway from TNF receptors to activation in TRAF22/2 cells (Figure 1C). Since hTNF only
NF-kB activation has largely been worked out (Rothe et binds to TNF-R1, it seems that TRAF2 plays a greater
al., 1994, 1995; Hsu et al., 1995, 1996a, 1996b). For TNF- role in TNF-R1-mediated IKK activation than it does in
R1-mediated NF-kB activation, it is thought that the the TNF-R2 pathway. Meanwhile, other TRAF proteins,
trimerization of TNF-R1 recruits TRADD to TNF-R1 and such as TRAF5, may also partially substitute the function
then TRADD recruits TRAF2 to the TNF-R1 complex. of TRAF2. In contrast, mTNF and hTNF showed no differ-
The aggregation of TRAF2 would then allow it to interact ence in activating IKK in RIP2/2 cells. It is intriguing to
with NIK, which leads to the subsequent activation of speculate that RIP is involved in both TNF-R1 and -R2
NIK. In turn, NIK would activate IKK, and the activated signaling pathways. This possibility is supported by the
IKK then phosphorylates IkB. Finally, the phosphory- fact that RIP interacts with TRAF1 and TRAF2, both of
lated IkB will be rapidly degraded after ubiquitination, which are components of the TNF-R2 complex (Hsu et
and NF-kB is translocated into the nucleus. However, al., 1996b).
this model does not address the importance of RIP in RIP was initially identified by its interaction with Fas,
TNF-induced NF-kB activation, although RIP is essential but it is not required for Fas-mediated apoptosis
for this process (Ting et al., 1996; Kelliher et al., 1998). (Stanger et al., 1995). It has also been reported that RIP
In our study, we demonstrated that both TRAF2 and RIP could weakly interact with TNF-R1 (Hsu et al., 1996b).
play essential and distinct roles in IKK activation. As Subsequently, RIP was found to be a key effector in
summarized in Figure 7, our data clearly indicated that the TNF-R1 complex (Liu et al., 1996; Ting et al., 1996;
IKK is recruited to the TNF-R1 complex and that TRAF2 Kelliher et al., 1998). In this study, we found that the
presence of RIP in the TNF-R1 complex is crucial foris essential for this recruitment. Although RIP has no
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IKK activation, although its kinase activity does not play activation by the oligomerization of the TRAF2 domain
a role in this process. Therefore, the essential role of also requires the presence of RIP. It is possible that the
RIP in TNF-R1-mediated IKK activation may be to bring oligomerization of the TRAF2 effector domain will result
the IKK kinase to the TNF-R1 complex. Our observation in RIP recruitment to the signaling complex.
that TRADD was recruited to TNF-R1 much more effi- TNF-induced NF-kB activation is achieved through
ciently in RIP2/2 cells than it was in wt cells suggests multiple steps. While the signaling pathway that leads
that RIP may bind to TNF-R1 directly instead of being to NF-kB activation in response to TNF has been largely
recruited to the TNF-R1 complex through TRADD as elucidated, the molecular mechanism for IKK activation
previously reported (Hsu et al., 1996b). Further study is is still not conclusive. In this report, we demonstrated
necessary to verify this possibility. Interestingly, al- the distinct roles of TRAF2 and RIP in TNF-R1-mediated
though much more TRAF2 was recruited to the TNF-R1 IKK activation. In order to be activated, IKK needs to
complex in RIP2/2 cells, the recruitment of IKK was not be recruited to the TNF-R1 complex. While TRAF2 is
increased (Figures 3A and 4A). These results imply that required for IKK recruitment, RIP mediates the activation
RIP may play a role in stabilizing the interaction between of IKK. Therefore, our study provided a mechanism for
TRAF2 and IKK. TNF-R1-mediated IKK activation.
TRAF2 has been suggested to play a critical role in
recruiting downstream kinases; several kinases, includ- Experimental Procedures
ing NIK and MEKK1, have been reported to interact with
ReagentsTRAF2 (Malinin et al., 1997; Song et al., 1997; Baud et
Anti-RIP antibody was purchased from Transduction Laboratories.al., 1999). Previous studies also reported that NIK and
Anti-TRAF2, anti-Xpress, anti-IKKa, anti-IKKb, anti-TNF-R2, anti-
MEKK1 could interact with IKK (Woronicz et al., 1997; TRADD, anti-HA, and anti-MEKK1 antibodies were purchased from
Nemoto et al., 1998). However, all of these observations Santa Cruz. Anti-JNK1, anti-IKKg, and anti-Myc antibodies were
were made by cotransfection experiments. More evi- from PharMingen. The anti-Flag antibody was purchased from
Sigma. Anti-IkB and anti-NIK antibodies were from Dr. DiDonato.dence is necessary to prove that these interactions in-
The anti-TNF-R1 antibodies were from R&D Systems. Human anddeed happen under physiological conditions. In our
mouse TNFa were purchased from R&D systems. [g-32P]ATP wasstudy, we failed to observe the presence of NIK or
from Amersham Pharmacia Biotech.MEKK1 in the TNF-R1 complex in our coimmunoprecipi-
tation experiments. One possibility is that the interaction Cell Culture and Transfection
between NIK or MEKK1 with the TNF-R1 complex is Wt fibroblasts were cultured in Dulbecco's modified Eagle's medium
supplemented with 10% fetal bovine serum or 10% calf serum, 2weak; therefore, it cannot be detected under our experi-
mM glutamine, 100 U/ml penicillin, and 100 mg/ml streptomycin.mental conditions. Because the presence of RIP in the
RIP2/2 and TRAF22/2 cells were cultured in the calf serum mediumTNF-R1 complex is critical for IKK activation, we are
as wt cells, except 0.3 mg/ml G418 was included. Cells were trans-currently investigating whether RIP interacts with NIK
fected with Lipofectamine PLUS reagent (GIBCO±BRL) following
or MEKK1. Most recently, another kinase, AKT, has also the instructions provided by the manufacturer. When cells were
been shown to play a role in TNF-induced NF-kB activa- transfected with the RIP plasmid, 0.1 mg CrmA was added. Jurkat
tion (Ozes et al., 1999). In contrast to what has been cells were cultured in RPMI 1640 medium supplemented with 10%
fetal bovine serum, 2 mM glutamine, 100 U/ml penicillin, and 100reported, we found that AKT is not linked to TNF-
mg/ml streptomycin. The stable TRAF2(87-501)-TRAF22/2 cell lineinduced IKK and NF-kB activation. In our system (mouse
was generated by cotransfecting Flag-TRAF2(87-501) and an ex-fibroblasts and Jurkat cells), wortmannin had no effect
pression plasmid for the hygromycin-resistant gene. Cell lines thaton TNF-induced IKK and NF-kB activation although it
are resistant to hygromycin were selected and examined for the
completely abolished AKT activation (Y. R. and Z-G. L., presence of Flag-TRAF2(87-501) by Western blotting with an anti-
unpublished data). While we were unable to detect the Flag antibody.
interaction between TRAF2 with these kinases, we found
Plasmidsthat IKK was recruited to the TNF-R1 complex in re-
The mammalian expression plasmids for Myc-RIP, Myc-RIP(K45A),sponse to TNF treatment. The rapid recruitment of IKK
and Flag-TRAF2 have been described previously (Hsu et al., 1996b;to the TNF-R1 signaling complex allows IKK to be effi-
Liu et al., 1996). The mammalian expression plasmids for Xpress-ciently activated. The recruitment of IKK to the TNF-R1 RIP and Xpress-RIP(K45A) have been described previously (Lin et
complex relies on the presence of TRAF2; RIP has little al., 1999). The expression plasmid for HA-IKKb has been described
effect on IKK recruitment. Although our preliminary data previously (Zandi et al., 1997).
suggested that TRAF2 directly interacted with IKK, the
Western Blot Analysis and Coimmuneprecipitationbiochemical basis for TRAF2-mediated IKK recruitment
After treatment with TNFa for different times as described in theis under study. However, because the TRAF2 mutant
figure legend, cells were washed twice in phosphate-buffered salineTRAF2(87-501) was unable to recruit IKK (Figure 5), one
(pH 7.2) and then collected and lysed in M2 buffer (20 mM Tris [pH
of the functions of the ring domain of TRAF2 is to medi- 7], 0.5% NP40, 250 mM NaCl, 3 mM EDTA, 3 mM EGTA, 2 mM
ate IKK recruitment. DTT, 0.5 mM PMSF, 20 mM b-glycerol phosphate, 1 mM sodium
Recently, it was found that the oligomerization of the vanadate, 1 mg/ml leupeptin, 1 mg/ml aprotinin, 1 mg/ml pepstatin,
N-terminal effector domain of TRAF2 was sufficient to and 10 mM pNpp). Fifty micrograms of the cell lysates were fraction-
ated by 4%±20% SDS-polyacrylamide gels, and Western blottingsinduce IKK activation (Baud et al., 1999). Because our
were performed with the desired antibodies. The proteins were visu-data indicated a pivotal role of RIP in TNF-induced IKK
alized by enhanced chemiluminescence, according to the manufac-activation, we tested whether RIP is required for IKK
turer's (Amersham) instructions. For immunoprecipitation assays,
activation by the oligomerization of the TRAF2 effector 3 3 107 of TNF- (40 ng/ml) treated or nontreated wt, RIP2/2, and
domain. We found that the aggregation of the TRAF2 TRAF22/2 fibroblasts were lysed in lysis buffer (50 mM HEPES [pH
effector domain did not induce IKK activation in RIP2/2 7.6], 250 mM NaCl, 0.1% NP40, 5 mM EDTA, 0.5 mM PMSF, 1 mg/
ml leupeptin, 1 mg/ml aprotinin, and 1 mg/ml pepstatin). The lysatescells (data not shown). This result indicated that IKK
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were mixed and precipitated with the relevant antibody and protein Hsu, H., Xiong, J., and Goeddel, D.V. (1995). The TNF receptor-
1±associated protein TRADD signals cell death and NF-B activation.A-Sepharose beads by incubation at 48C for 4 hr to overnight. The
Cell 81, 495±504.beads were washed four times with lysis buffer, and the bound
proteins were resolved in 10% SDS-polyacrylamide gels and de- Hsu, H., Shu, H.B., Pan, M.P., and Goeddel, D.V. (1996a). TRADD-
tected by Western blot analysis. For immunoprecipitations with anti- TRAF2 and TRADD-FADD interactions define two distinct TNF re-
bodies that were cross-linked to protein A-Sepharose beads, anti- ceptor-1 signal transduction pathways. Cell 84, 299±308.
bodies (100 mg antibody/ml wet beads) were coupled to the beads Hsu, H., Huang, J., Shu, H.B., Baichwal, V., and Goeddel, D.V.
with dimethyl pimelimidate (DMP) as described (Harlow and Lane, (1996b). TNF-dependent recruitment of the protein kinase RIP to
1999). the TNF receptor-1 signaling complex. Immunity 4, 387±396.
Hu, Y., Baud, V., Delhase, M., Zhang, P., Deerinck, T., Ellisman, M.,
Johnson, R., and Karin, M. (1999). Abnormal morphogenesis butKinase Assay
intact IKK activation in mice lacking the IKKalpha subunit of IkappaBCells were collected in M2 buffer (see above). Endogenous IKK was
kinase. Science 284, 316±320.immunoprecipitated with anti-IKKa antibody, and in vitro kinase
assays were performed as described previously, using GST-IkB(1- Karin, M. (1995). The regulation of AP-1 activity by mitogen-activated
54) as the substrate (DiDonato et al., 1997). HA-IKK was immunopre- protein kinases. J. Biol. Chem. 270, 16483±16486.
cipitated with anti-HA antibody. For the kinase assay with anti-TNF- Karin, M., Liu, Z.G., and Zandi, E. (1997). AP-1 function and regula-
R1 immunoprecipitants, GST-IkB(1-54) and [g-32P]ATP were mixed tion. Curr. Opin. Cell Biol. 9, 240±246.
directly with them in the kinase buffer (20 mM HEPES [pH 7.5], 20
Kelliher, M.A., Grimm, S., Ishida, Y., Kuo, F., Stanger, B.Z., and
mM b-glycerol-phosphate, 10 mM pNpp, 10 mM MgCl2, 1 mM DTT, Leder, P. (1998). The death domain kinase RIP mediates the TNF-
50 mM sodium vanadate, and 20 mM cold ATP).
induced NF-kappaB signal. Immunity 8, 297±303.
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